Leverage AI for Operational Excellence and Strategic Cost Management
Prepare for industry headwinds and enhance operational excellence in life sciences
The life sciences industry faces mounting pressures: patent cliffs, geopolitical uncertainty, regulatory, and legislative changes threaten drug prices and revenue over the next five years. To stay competitive, strategic cost reduction and reinvestment are essential. Traditional cost-cutting methods are falling short, but integrating artificial intelligence (AI) with innovative operating models is delivering transformative, sustainable savings.
Watch this exclusive webcast replay where Sanofi, AstraZeneca and Merck Group executives reveal AI-driven strategies for:
Achieving operational excellence and significant cost savings
Unlocking targeted opportunities in operations and service delivery while avoiding common pitfalls
Creating the conditions for maximum, sustainable AI value and return on investment
Discover how to drive rapid, measurable impact by leveraging AI and smarter business operations for strategic cost management.
Featured Panelists
Jeremy Goldnadel, Senior Vice President, Business Operations, Head of Global Manufacturing and Supply Services, Sanofi